Should aspirin be used for primary prevention of thrombotic events in patients with membranous nephropathy?
Publication year
2016Source
Kidney International. Supplement, 89, 5, (2016), pp. 981-3ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Nephrology
Journal title
Kidney International. Supplement
Volume
vol. 89
Issue
iss. 5
Page start
p. 981
Page end
p. 3
Subject
Radboudumc 11: Renal disorders RIHS: Radboud Institute for Health SciencesAbstract
Patients with nephrotic syndrome are at increased risk of thrombosis. The risk of venous thrombosis is particularly high in patients with nephrotic syndrome due to primary membranous nephropathy. Recent data provide evidence that these patients also have a high absolute risk of arterial thrombotic events, which is associated with the degree of hypoalbuminemia. In this commentary we discuss whether prophylactic aspirin therapy might be indicated in this patient population.
This item appears in the following Collection(s)
- Academic publications [245050]
- Faculty of Medical Sciences [93209]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.